Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 1.25% | 67.84 | 1.0% | $996.23m | |
| BIIB | Biogen, Inc. | 0.15% | 337.15 | 1.5% | $676.13m | |
| AMGN | Amgen, Inc. | 0.14% | 222.44 | 1.3% | $549.13m | |
| ILMN | Illumina, Inc. | -0.67% | 298.44 | 3.5% | $419.18m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.55% | 396.95 | 2.6% | $352.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.05% | 244.99 | 1.9% | $341.98m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.13% | 102.67 | 2.0% | $217.58m | |
| A | Agilent Technologies, Inc. | -0.73% | 83.73 | 1.6% | $162.08m | |
| EXAS | EXACT Sciences Corp. | -2.55% | 100.02 | 24.0% | $160.61m | |
| SGEN | Seattle Genetics, Inc. | 0.10% | 118.45 | 6.1% | $114.87m | |
| INCY | Incyte Corp. | -0.65% | 82.24 | 2.5% | $113.52m | |
| MRNA | Moderna, Inc. | -1.94% | 18.18 | 0.0% | $104.70m | |
| XLRN | Acceleron Pharma, Inc. | -0.17% | 94.69 | 6.1% | $94.00m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -2.14% | 130.27 | 8.7% | $92.41m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 3.29% | 92.61 | 4.3% | $91.80m |
Company Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.